Hemogenyx Pharmaceuticals

Timeline

Health & Bio Today: GSK, AstraZeneca, Hemogenyx Pharmaceuticals, Genflow Biosciences

17:04, 28 Apr 2026

Hemogenyx Pharmaceuticals shares fall after £3m fundraising

07:36, 28 Apr 2026 · Updated 14:21, 28 Apr

More in Telecoms

Telecoms

Vodafone Group shares soar after stake sale to Xavier Niel

French billionaire Xavier Niel is investing in Vodafone Group via his Vega entity, with funding provided entirely by Niel personally and financial institutions.

Updated 12:43, 10 Jul 2026

Cybersecurity

BATM secures three-year contract extension with major US broadband operator

07:43, 6 Jul 2026

AI & Machine Learning

Tech Today: Craneware warns FY26 revenue and profit to miss expectations, MedPal AI, Crimson Tide, Quantum Blockchain Technologies, Defence Holdings

17:04, 3 Jul 2026

Medtech & Diagnostics

MedPal AI raises £5m to acquire care-home software firm and launch oral Wegovy clinic

07:53, 3 Jul 2026

Hardware & Electronics

Tech Today: Shearwater lands £25m contract extension, Iconic Labs, MedPal AI, Amcomri

17:03, 1 Jul 2026

Cybersecurity

Shearwater Group shares up sharply on £25m contract extension

Updated 12:19, 1 Jul 2026

Healthcare Services

MedPal AI opens largest robotic dispensing facility in Runcorn with NHS approval

10:06, 1 Jul 2026

Software & SaaS

Tech Today: Made Tech beats upgraded guidance, Chill Brands, CloudCoCo, PipeHawk, GenIP, Smarter Web Company

17:04, 30 Jun 2026

Retail

Chill Brands revenue grows, but financials show investment outpaced income

12:47, 30 Jun 2026

Biotech

Oxford BioDynamics shows revenue growth, new CEO starts, and lands a new US partnership

09:27, 30 Jun 2026

Telecoms

Tech Today: BT and Verizon merge international units in $4bn JV, Cloudified, Arcontech, Trustpilot

17:33, 29 Jun 2026

Hemogenyx Pharmaceuticals is a clinical-stage biopharmaceutical company developing therapies for blood disorders and cancers, with a focus on gene therapy and cell therapy approaches. The company operates in the UK and is listed on the London Stock Exchange's AIM market, positioning it within the small-cap biotech segment. As a pre-revenue clinical-stage entity, Hemogenyx is dependent on capital raises and partnerships to fund its pipeline advancement toward regulatory milestones.

Sector: Telecoms
Market: MAINMARKET

Identifiers

Ticker: LSE:HEMO
Market: MAINMARKET
ISIN: GB00BQVXM815
LEI: 2138008L93GYU5GN6179

Learn more on:

GLEIF Companies House

Timeline

Health & Bio Today: GSK, AstraZeneca, Hemogenyx Pharmaceuticals, Genflow Biosciences